Novel glycine transporter type-2 reuptake inhibitors. Part 2: beta- and gamma-amino acid derivatives

Bioorg Med Chem. 2004 Aug 15;12(16):4493-509. doi: 10.1016/j.bmc.2004.05.043.

Abstract

Several beta- and gamma-amino acid derivatives were prepared as glycine transport inhibitors and their ability to block the uptake of [(14)C]-glycine in COS7 cells transfected with human glycine transporter-2 (hGlyT-2) were evaluated. A range of lipophilic side chains were tolerated in the beta-amino acid series (i.e., Ph, CH(2)Ph, CH(CH(3))(2), and CH(2)CH(CH(3))(2)). In the gamma-amino acid series, minimal differences in potency were observed between the alpha,beta-unsaturated analogs and the corresponding saturated derivatives. In both series, a 4-biphenyl or 4-phenoxyphenyl substituent appended to the urea or cyanogunaidine moiety was necessary for in vitro activity.

MeSH terms

  • Amino Acid Transport Systems, Neutral / antagonists & inhibitors*
  • Amino Acid Transport Systems, Neutral / genetics
  • Amino Acids / chemical synthesis
  • Amino Acids / chemistry*
  • Amino Acids / pharmacology*
  • Animals
  • Biological Transport / drug effects
  • COS Cells
  • Chlorocebus aethiops
  • Glycine / metabolism
  • Glycine Plasma Membrane Transport Proteins
  • Guanidines / chemistry
  • Neurotransmitter Uptake Inhibitors / chemical synthesis
  • Neurotransmitter Uptake Inhibitors / chemistry*
  • Neurotransmitter Uptake Inhibitors / pharmacology*

Substances

  • Amino Acid Transport Systems, Neutral
  • Amino Acids
  • Glycine Plasma Membrane Transport Proteins
  • Guanidines
  • Neurotransmitter Uptake Inhibitors
  • dicyandiamido
  • Glycine